Definitive Contract 75D30121C11269
Award Date
6/10/21
Potential Completion Date
6/6/26
Potential Value
$2.1M
Federal Agency
CDC Pittsburgh
Awardee
PPD Development LP
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Siris Pharmaceutical Services LLC, a woman-owned small business, to provide tuberculosis (TB) clinical trials management support. The contract has a ceiling value of $2,395,614.70 and is a time and materials contract with a period of performance ending on September 10, 2026. The contract is designated as a total small business set-aside. This contract supports the CDC's efforts to advance TB research...
This is a $28,578,960 definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The contract is for clinical site monitoring services in support of NIAID's various clinical research programs, trials, and studies. It has a 10-year period of performance and was awarded on a full and open basis without a set-aside designation. The...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, with a ceiling value of $15,729,937.34. The contract is for tuberculosis trials and consortium services over a 10-year period of performance from January 1, 2021 to December 31, 2030. There is no set-aside designation for this award. The contract requires the vendor to...
This federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Weill Medical College of Cornell University, doing business as Joan & Sanford I Weill Medical College of Cornell University, for tuberculosis trials and consortium services. The 10-year, $5,917,206.24 contract is a definitive, cost-no-fee contract that does not have a set-aside designation. The contract supports clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis,...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO), for R&D services related to biomedical basic research. The $27,437,431.92 contract has a performance period ending on October 31, 2021 and is not set aside for any specific business type. PPD Development LP has been awarded over $500 million in prime federal...
This is a delivery order under the Medical Countermeasures Clinical Studies Network contract vehicle, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development, LP, a global contract research organization (CRO). The $6,186,155.39 delivery order is for a H5N1 clinical study, under a cost-plus-fixed-fee contract type. PPD Development, LP has been awarded over $500 million in prime federal contracts and participated as a subcontractor on grants and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The $2,791,811.00 cost-plus-fixed-fee delivery order contract is for the implementation of Phase 0 to Phase II clinical trials, including proof-of-concept studies in healthy and diseased human populations, both domestically and internationally, supported by bioanalysis as needed. Phase III studies may...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County, for tuberculosis trials and consortium services. The $10,667,136.30 contract has an ultimate completion date of December 31, 2030. It does not have a set-aside designation, indicating it was competed on a full and open basis. The contract will support clinical trials and research on the treatment, diagnosis, and prevention of...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization (CRO). The contract, valued at $64,031,927.00, is for completing the ACTIV 2 study to support COVID-19 research. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher...